Mabwell Announces the NMPA Approval of Novel Trop-2 ADC (9MW2921)

Mabwell has announced the approval of clinical trial application for 9MW2921 by the National Medical Products Administration (NMPA) for the treatment of advanced solid tumours. 9MW2921 is developed by Mabwell's novel antibody-drug conjugate plateform IDDC™.

9MW2921 is an advanced antibody-drug conjugate (ADC) that has been developed using the IDDC™ (Interchain-Disulfide Drug Conjugate) platform specifically for the treatment of solid tumours.

9MW2921 exhibits specific binding to antigens present on the cell membrane surface of tumour cells. This specific binding is facilitated by the antibody component of the ADC, which recognises and attaches to the target antigens.

9MW2921 is a pharmaceutical compound that possesses several desirable characteristics. It is characterised by a stable structure, homogeneous composition, and high purity, making it suitable for industrial scale-up.

9MW2921 demonstrates an improved bystander killing effect. The bystander effect refers to the ability of a drug to induce cell death in neighbouring cells, even if they do not directly interact with the drug. By enhancing this effect, 9MW2921 can increase its overall efficacy by attacking not only the target cells but also the surrounding tumour microenvironment

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!